Professor, Radiation Oncology, Cooper Medical School of Rowan Univ
Radiation Oncology
Dr. Sucha O. Asbell, MD
|
|
Give Review
Sucha O. Asbell, MD is an expert in the field of Radiation Oncology. Sucha Asbell is a published MD. She has 100 papers published. The most current publication "Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in in..." Doctor Sucha O. Asbell, MD accepts Medicare payments and is registered with Medicare.gov.
Publications
- Introduction and Clinical Overview of the DVH Risk Map.
- Quantifying rigid and nonrigid motion of liver tumors during stereotactic body radiation therapy.
- The importance of protein kinase A in prostate Cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.
- Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy...
- Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.
- Race and survival of men treated for prostate Cancer on radiation therapy oncology group phase III randomized trials.
- Low toxicity for lung tumors near the mediastinum treated with stereotactic body radiation therapy.
- Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic Cancer.
- Letter: Ectopic production of hormones in tumors.
- Efficacy of local graft irradiation in preventing cadaveric renal transplant rejection: a prospective randomized trial.
- Single-dose half-body irradiation for the palliation of multiple bone metastases from solid tumors: a preliminary report.
- Changing face and different countenances of prostate Cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era.
- Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials.
- Recursive partitioning analysis of 1999 Radiation Therapy Oncology Group (RTOG) patients with locally-advanced non-small-cell lung Cancer (LA-NSCLC): identification of...
- Survival advantage from higher-dose radiation therapy for clinically localized prostate Cancer treated on the Radiation Therapy Oncology Group trials.
- Tolerance of pelvic normal tissues to hyperfractionated radiation therapy: results of Protocol 83-08 of the Radiation Therapy Oncology Group.
- Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectiv...
- Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.
- Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncolo...
- Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung Cancer.
- Outcome for lymph node dissection negative T-1b, T-2 (A-2,B) prostate Cancer treated with external beam radiation therapy in RTOG 77-06.
- A randomized prospective trial comparing full dose chemotherapy to 131I antiferritin: an RTOG study.
- A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916).
- Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: analysis of 1244...
- Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.
- White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Onc...
- Treatment related sequelae following external beam radiation for prostate Cancer: a review with an update in patients with stages T1 and T2 tumor.
- Late effects of hyperfractionated radiotherapy for advanced head and neck Cancer: long-term follow-up results of RTOG 83-13.
- PSA confirmation of cure at 10 years of T1B, T2, N0, M0 prostate Cancer patients treated in RTOG protocol 7706 with external beam irradiation.
- Individualized eye shields for use in electron beam therapy as well as low-energy photon irradiation.
- CT scanning in the male genital tract and in recurrent rectal carcinoma: a review.
- Revision of treatment planning for carcinoma of the prostate.
- Radiation therapy.
- Malignant lymphoma of the gastrointestinal tract. Erskine Memorial Lecture, 1979.
- Misonidazole and unconventional radiation in advanced squamous cell carcinoma of the esophagus: a phase II study of the Radiation Therapy Oncology Group.
- Surgical staging in carcinoma of the prostate: the RTOG experience. Radiation Therapy Oncology Group.
- Treatment-related morbidity in phase III RTOG studies of extended-field irradiation for carcinoma of the prostate.
- Preliminary report on phase III RTOG studies of extended-field irradiation in carcinoma of the prostate.
- Palliation of liver metastases with combined hepatic irradiation and misonidazole. Results of a Radiation Therapy Oncology Group Phase I-II study.
- Oxygen effect on the production of radiation-induced myelitis in rats.
- The use of thermography in the detection of metastatic liver disease.
- Preoperative radiation therapy. A plan for combined therapy by the Radiation Therapy Oncology Group and the Central Oncology Group.
- The management of carcinoma involving the cervix and body of the uterus.
- Evolution of radiotherapeutic techniques.
- Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease.
- Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06.
- Definitive radiotherapy in resectable (stage A2 and B) carcinoma of the prostate--results of a nationwide overview.
- Radical prostatectomy or radiotherapy in carcinoma of prostate. The dilemma continues.
- Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG phase III study for A2 and B prostate carcinoma.
- Variation of lung density corrections in a typical patient population.
- Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
- Single-dose half-body irradiation for palliation of multiple bone metastases from solid tumors. Final Radiation Therapy Oncology Group report.
- Accelerated fractionation radiation therapy for liver metastases: selection of an optimal patient population for the evaluation of late hepatic injury in RTOG studies.
- Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.
- The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: the Radiation Therapy Oncology Group 75-06 and 77-06 e...
- Evaluation and recommendations for therapy of advanced mycosis fungoides lymphoma.
- Antibody-dependent cellular cytotoxicity in patients with mycosis fungoides and Sézary syndrome.
- Prognostic factors in unresectable hepatocellular Cancer: Radiation Therapy Oncology Group Study 83-01.
- Biopsies of non-small cell lung Cancer: central review in cooperative studies of the Radiation Therapy Oncology Group.
- Comparison of pathologic and clinical evaluation of lymph nodes in prostate Cancer: implications of RTOG data for patient management and trial design and stratification.
- Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
- The prognostic significance of race and survival from prostate Cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985).
- Effect of acute and fractionated partial body x-irradiation on circulating immunoglobulin levels in mice.
- Topical chemotherapy and immunotherapy of mycosis fungoides: intermediate-term results.
- The use of computerized tomography scanning in treatment planning for bladder carcinoma.
- Subtotal mastectomy and radiation therapy in the definitive management of localized breast malignancy.
- Dose-volume histograms can be interpreted in different ways.
- Impact of adding concurrent chemotherapy to hyperfractionated radiotherapy for locally advanced non-small cell lung Cancer (NSCLC): comparison of RTOG 83-11 and RTOG 9...
- Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.
- Racial differences in prostate-specific antigen levels in patients with local-regional prostate Cancer.
- Development of anemia and recovery in prostate Cancer patients treated with combined androgen blockade and radiotherapy.
- Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in Cancer patients.
- Recursive partitioning analysis of 2105 patients treated in Radiation Therapy Oncology Group studies of head and neck Cancer.
- Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group.
- Effects of hyperthermia on bone. II. Heating of bone in vivo and stimulation of bone growth.
- Effects of hyperthermia on bone. I. Heating rate patterns induced by microwave irradiation in bone and muscle phantoms.
- CT characteristics of patients with brain metastases treated in RTOG study 79-16.
- Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Gr...
- Patterns of Care and RTOG studies in prostate Cancer: long-term survival, hazard rate observations, and possibilities of cure.
- Evaluation of 45 degrees C hyperthermia and irradiation. II. A phase I clinical trial in humans by the Radiation Therapy Oncology Group.
- Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
- Predicting long-term survival, and the need for hormonal therapy: a meta-analysis of RTOG prostate Cancer trials.
- Four prognostic groups predict long-term survival from prostate Cancer following radiotherapy alone on Radiation Therapy Oncology Group clinical trials.
- Racial differences in prostate Cancer related to loss of heterozygosity on chromosome 8p12-23.
- Does race influence survival for esophageal Cancer patients treated on the radiation and chemotherapy arm of RTOG #85-01?
- Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
- Chemoradiotherapy of locally advanced esophageal Cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.
- Long-term survival after radiotherapy alone: radiation therapy oncology group prostate Cancer trials.
- Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in in...
- Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns H...
- Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Grou...
- An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG ...
- Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical Cancer with positive para-aortic or high common iliac lymp...
- Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and...
- Prognostic value of p16 in locally advanced prostate Cancer: a study based on Radiation Therapy Oncology Group Protocol 9202.
- The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung Cancer: an analysis of RTOG data.
- Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06.
- Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1BN0M0 (A2) and T2N0M0 (B) prostate carcinoma.
- Prostate-specific antigen and androgens in African-American and white normal subjects and prostate Cancer patients.
Schools
Medical College of Pennsylvania
Jefferson Hospital
Thomas Jefferson University Hospital
Procedures Preformed
- Cancer Pain Management
- Image-Guided Radiation Therapy (IGRT)
- Radiation Therapy
- Stereotactic Radiosurgery
Conditions Treated
- Cancer
- Vulvar Cancer
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Education
-
Thomas Jefferson University
Hospital
-
Cooper University Health Care -
Einstein Medical Center Philadelphia -
Crozer-Chester Medical Center
Drug Facts
| NPI NUMBER | 1770699605 | |
| NPPES Provider LastName | ASBELL | |
| NPPES Provider FirstName | SUCHA | |
| NPPES Provider ZIPCode | 081031461 | |
| NPPES Provider State | NJ | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 175.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 24.0 | |
| Percent Opioid Claims | 13.71 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1770699605 |
| Last Name Of The Provider | ASBELL |
| First Name Of The Provider | SUCHA |
| View All |
Similar Doctors
|
Michael D. Stambaugh, MS
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven J. Dibiase, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Tamara A. Lacouture, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jyoti S. Kalra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel L. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashraf F. Youssef, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lesley A. Hughes, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory M. Richards, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gregory J. Kubicek, MD
This Doctor is OpenDoctor Recommended.
|